Ph.D. Noubar B. Afeyan - Director, 10%+ Owner at Generate Biomedicines, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
GENB
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ph.D. Noubar B. Afeyan since 04 Mar 2025

Holdings reported by Ph.D. Noubar B. Afeyan for Generate Biomedicines, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 25,016,458 26 Feb 2026 By Flagship VentureLabs VI, LLC
Common Stock 15,264,724 02 Mar 2026 By Flagship Pioneering Fund VII, L.P.
Common Stock 12,723,940 02 Mar 2026 By Flagship Pioneering Fund VI, L.P.
Common Stock 4,340,252 02 Mar 2026 By FPN II, L.P.
Common Stock 2,777,752 02 Mar 2026 By Flagship Pioneering Special Opportunities Fund II, L.P.
Common Stock 1,562,500 02 Mar 2026 By Pioneering Medicines 02, LLC
Common Stock 987,491 02 Mar 2026 By Nutritional Health LTP Fund, L.P.
Stock Option (Right to Buy) 29,561 26 Feb 2026 Direct Common Stock
Series A Preferred Stock 0 02 Mar 2026 By Flagship Pioneering Fund VII, L.P. Common Stock
Series A Preferred Stock 0 02 Mar 2026 By Flagship Pioneering Fund VI, L.P. Common Stock
Series A Preferred Stock 0 02 Mar 2026 By Nutritional Health LTP Fund, L.P. Common Stock
Series B Preferred Stock 0 02 Mar 2026 By Flagship Pioneering Fund VII, L.P. Common Stock
Series B Preferred Stock 0 02 Mar 2026 By Flagship Pioneering Fund VI, L.P. Common Stock
Series B Preferred Stock 0 02 Mar 2026 By Flagship Pioneering Special Opportunities Fund II, L.P. Common Stock
Series B Preferred Stock 0 02 Mar 2026 By FPN II, L.P. Common Stock
Series C Preferred Stock 0 02 Mar 2026 By Flagship Pioneering Fund VII, L.P. Common Stock
Series C Preferred Stock 0 02 Mar 2026 By Flagship Pioneering Special Opportunities Fund II, L.P. Common Stock
Series C Preferred Stock 0 02 Mar 2026 By FPN II, L.P. Common Stock

Transactions reported by Ph.D. Noubar B. Afeyan for Generate Biomedicines, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.